Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
JNJ submitted an NDA to FDA for doripenem to treat nosocomial pneumonia. JNJ gained the broad-spectrum carbapenem antibiotic through its acquisition of Peninsula Pharmaceuticals Inc. (see BioCentury,...